Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF (PDBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $19.76 (market cap $7.96B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 3.9× Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF pays none. Which is the better fit depends on your goals.
| GEHC | PDBC | |
|---|---|---|
Market Cap | $31.07B | $7.96B |
Volume | 3,443,020 | 2,738,146 |
Sector | Health | — |
52-Week High | $88.16 | $20.10 |
52-Week Low | $59.48 | $13.19 |
Enterprise Value | $39.53B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 56 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
PDBC, an ETF tracking diversified commodities, trades at $19.98, up 0.6% today, with a bullish technical signal from moving averages. The fund has delivered strong performance, rising 45.66% year-to-date through Q3 2026, driven by energy and agricultural gains amid geopolitical tensions. Short interest surged 215.4% in September 2026, indicating increased bearish speculation, while institutional investments from firms like Arlington Capital and Advisortrust Partners show confidence.
The outlook remains positive due to robust commodity trends, but risks include heightened short interest and geopolitical volatility. Investors benefit from broad commodity exposure without K-1 tax complexity, though price swings from supply shocks or economic shifts pose challenges. The fund's momentum and defensive appeal in uncertain markets support a favorable view, but monitoring short-term pressure is essential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →
